ConductScience.org, home

Paper37474656

Functional T cell tolerance by peripheral tissue-based checkpoint control.

Carbone FR and 1 other. Nat Immunol, 2023. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Functional T cell tolerance by peripheral tissue-based checkpoint control. Papers, record 37474656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37474656

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Functional T cell tolerance by peripheral tissue-based checkpoint control.
PubMed
Journal
Nat Immunol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Comment
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.21
iCite
Revised in PubMed
2026-10-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carbone FRFrancis R
2Mackay LKLaura Khttps://orcid.org/0000-0002-8496-6632

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
T-LymphocytesMajor topic
Immune ToleranceMajor topic
Lymphocyte Activation

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on37344588PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens.https://conductscience.org/library/papers/37344588

Source PubMed

Download CSV of comments and corrections

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132719479Inducible de novo expression of neoantigens in tumor cells and mice.Nat Biotechnol2021https://conductscience.org/library/papers/32719479PubMed
231810882Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection.Immunity2019https://conductscience.org/library/papers/31810882PubMed
39670054Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction.J Exp Med1998https://conductscience.org/library/papers/9670054PubMed
437344588PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens.Nature2023https://conductscience.org/library/papers/37344588PubMed
527411054Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Immunotherapy.JAMA Dermatol2016https://conductscience.org/library/papers/27411054PubMed
629320654Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.N Engl J Med2018https://conductscience.org/library/papers/29320654PubMed
729567705Cancer immunotherapy using checkpoint blockade.Science2018https://conductscience.org/library/papers/29567705PubMed
815780985Peripheral tolerance of CD8 T lymphocytes.Immunity2005https://conductscience.org/library/papers/15780985PubMed
925769925Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.J Immunol2015https://conductscience.org/library/papers/25769925PubMed
1025992863Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes.Immunity2015https://conductscience.org/library/papers/25992863PubMed
1110535986CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10535986PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
40783607Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer.Sci Rep2025https://conductscience.org/library/papers/40783607PubMed
40637269Bacterial Foreignization Nanosystem Elicits Multi-Phenotypic T Cells for Antitumor Immunity.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40637269PubMed
40045029Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy.Curr Treat Options Oncol2025https://conductscience.org/library/papers/40045029PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37474656

GET https://conductscience.org/api/papers/v1/37474656/authors